Invirase - Big Patent Expirations of 2010
Drug: Invirase (saquinavir mesylate)
Company: Roche
Indication: HIV
Expiration Date: Nov. 19
Scoop: The patent covering Invirase, an HIV drug, expires this November. Currently, there are no generic products with tentative approval.
More stories about Invirase
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: